SHINE is also one of the DOE/NNSA's cooperative agreement partners. As announced in October 2021, NNSA awarded SHINE an additional $35 million to support their efforts to produce Mo-99 commercially by the end of 2023. This award is part of the DOE/NNSA financial assistance efforts to establish a reliable, U.S.-produced supply of Mo-99, without using highly enriched uranium. NNSA has implemented this effort by competitively awarding cost-shared cooperative agreements to commercial entities, as well as providing funds to DOE's National Laboratories to support development of non-highly enriched uranium Mo-99 production technologies.
Learn more about NNSA efforts to establish a reliable supply of Mo‑99 without the use of highly enriched uranium.
Ad Statistics
Times Displayed: 30632
Times Visited: 779 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Learn more about SHINE's efforts to deploy fusion technology to establish a reliable supply of Mo‑99 without the use of highly enriched uranium.
About SHINE Technologies
SHINE is a next-generation nuclear technology company focused on deploying state-of-the-art fusion technology to help solve global problems as a scalable path to practical fusion energy.
Back to HCB News
